153 related articles for article (PubMed ID: 38290608)
1. Allogeneic hematopoietic cell transplantation is effective for p47phox chronic granulomatous disease: A Primary Immune Deficiency Treatment Consortium study.
Grunebaum E; Arnold DE; Logan B; Parikh S; Marsh RA; Griffith LM; Mallhi K; Chellapandian D; Lim SS; Deal CL; Kapoor N; Murguía-Favela L; Falcone EL; Prasad VK; Touzot F; Bleesing JJ; Chandrakasan S; Heimall JR; Bednarski JJ; Broglie LA; Chong HJ; Kapadia M; Prockop S; Dávila Saldaña BJ; Schaefer E; Bauchat AL; Teira P; Chandra S; Parta M; Cowan MJ; Dvorak CC; Haddad E; Kohn DB; Notarangelo LD; Pai SY; Puck JM; Pulsipher MA; Torgerson TR; Malech HL; Kang EM; Leiding JW
J Allergy Clin Immunol; 2024 May; 153(5):1423-1431.e2. PubMed ID: 38290608
[TBL] [Abstract][Full Text] [Related]
2. Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCT.
Marsh RA; Leiding JW; Logan BR; Griffith LM; Arnold DE; Haddad E; Falcone EL; Yin Z; Patel K; Arbuckle E; Bleesing JJ; Sullivan KE; Heimall J; Burroughs LM; Skoda-Smith S; Chandrakasan S; Yu LC; Oshrine BR; Cuvelier GDE; Thakar MS; Chen K; Teira P; Shenoy S; Phelan R; Forbes LR; Chellapandian D; Dávila Saldaña BJ; Shah AJ; Weinacht KG; Joshi A; Boulad F; Quigg TC; Dvorak CC; Grossman D; Torgerson T; Graham P; Prasad V; Knutsen A; Chong H; Miller H; de la Morena MT; DeSantes K; Cowan MJ; Notarangelo LD; Kohn DB; Stenger E; Pai SY; Routes JM; Puck JM; Kapoor N; Pulsipher MA; Malech HL; Parikh S; Kang EM;
J Clin Immunol; 2019 Oct; 39(7):653-667. PubMed ID: 31376032
[TBL] [Abstract][Full Text] [Related]
3. Lentiviral gene therapy for X-linked chronic granulomatous disease.
Kohn DB; Booth C; Kang EM; Pai SY; Shaw KL; Santilli G; Armant M; Buckland KF; Choi U; De Ravin SS; Dorsey MJ; Kuo CY; Leon-Rico D; Rivat C; Izotova N; Gilmour K; Snell K; Dip JX; Darwish J; Morris EC; Terrazas D; Wang LD; Bauser CA; Paprotka T; Kuhns DB; Gregg J; Raymond HE; Everett JK; Honnet G; Biasco L; Newburger PE; Bushman FD; Grez M; Gaspar HB; Williams DA; Malech HL; Galy A; Thrasher AJ;
Nat Med; 2020 Feb; 26(2):200-206. PubMed ID: 31988463
[TBL] [Abstract][Full Text] [Related]
4. Genotype, oxidase status, and preceding infection or autoinflammation do not affect allogeneic HCT outcomes for CGD.
Leiding JW; Arnold DE; Parikh S; Logan B; Marsh RA; Griffith LM; Wu R; Kidd S; Mallhi K; Chellapandian D; Si Lim SJ; Grunebaum E; Falcone EL; Murguia-Favela L; Grossman D; Prasad VK; Heimall JR; Touzot F; Burroughs LM; Bleesing J; Kapoor N; Dara J; Williams O; Kapadia M; Oshrine BR; Bednarski JJ; Rayes A; Chong H; Cuvelier GDE; Forbes Satter LR; Martinez C; Vander Lugt MT; Yu LC; Chandrakasan S; Joshi A; Prockop SE; Dávila Saldaña BJ; Aquino V; Broglie LA; Ebens CL; Madden LM; DeSantes K; Milner J; Rangarajan HG; Shah AJ; Gillio AP; Knutsen AP; Miller HK; Moore TB; Graham P; Bauchat A; Bunin NJ; Teira P; Petrovic A; Chandra S; Abdel-Azim H; Dorsey MJ; Birbrayer O; Cowan MJ; Dvorak CC; Haddad E; Kohn DB; Notarangelo LD; Pai SY; Puck JM; Pulsipher MA; Torgerson TR; Malech HL; Kang EM
Blood; 2023 Dec; 142(24):2105-2118. PubMed ID: 37562003
[TBL] [Abstract][Full Text] [Related]
5. Effect of allogeneic hematopoietic stem cell transplantation for chronic granulomatous disease in children: A multicentre, retrospective cohort study in China.
Si Y; Dou Y; Zhai X; Zhou C; Lu W; Meng Y; Qian X; Chen J; Wang P; Luo C; Yu J; Tang X
Clin Immunol; 2024 Mar; 260():109919. PubMed ID: 38309448
[TBL] [Abstract][Full Text] [Related]
6. Hematopoietic Cell Transplantation for Chronic Granulomatous Disease in Japan.
Yanagimachi M; Kato K; Iguchi A; Sasaki K; Kiyotani C; Koh K; Koike T; Sano H; Shigemura T; Muramatsu H; Okada K; Inoue M; Tabuchi K; Nishimura T; Mizukami T; Nunoi H; Imai K; Kobayashi M; Morio T
Front Immunol; 2020; 11():1617. PubMed ID: 32849547
[TBL] [Abstract][Full Text] [Related]
7. Febrile neutropenia management and outcomes in hematopoietic cell transplantation for chronic granulomatous disease.
Parta M; Cuellar-Rodriguez J; Gea-Banacloche J; Qin J; Kelly C; Zerbe CS; Holland SM; Malech HL; Kang EM
Transpl Infect Dis; 2022 Apr; 24(2):e13815. PubMed ID: 35191140
[TBL] [Abstract][Full Text] [Related]
8. Experience with a Reduced Toxicity Allogeneic Transplant Regimen for Non-CGD Primary Immune Deficiencies Requiring Myeloablation.
Chandra S; Chandrakasan S; Dávila Saldaña BJ; Bleesing JJ; Jordan MB; Kumar AR; Grimley MS; Krupski C; Davies SM; Khandelwal P; Marsh RA
J Clin Immunol; 2021 Jan; 41(1):89-98. PubMed ID: 33067658
[TBL] [Abstract][Full Text] [Related]
9. Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experience.
Morillo-Gutierrez B; Beier R; Rao K; Burroughs L; Schulz A; Ewins AM; Gibson B; Sedlacek P; Krol L; Strahm B; Zaidman I; Kalwak K; Talano JA; Woolfrey A; Fraser C; Meyts I; Müller I; Wachowiak J; Bernardo ME; Veys P; Sykora KW; Gennery AR; Slatter M
Blood; 2016 Jul; 128(3):440-8. PubMed ID: 27216217
[TBL] [Abstract][Full Text] [Related]
10. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
11. Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study.
Güngör T; Teira P; Slatter M; Stussi G; Stepensky P; Moshous D; Vermont C; Ahmad I; Shaw PJ; Telles da Cunha JM; Schlegel PG; Hough R; Fasth A; Kentouche K; Gruhn B; Fernandes JF; Lachance S; Bredius R; Resnick IB; Belohradsky BH; Gennery A; Fischer A; Gaspar HB; Schanz U; Seger R; Rentsch K; Veys P; Haddad E; Albert MH; Hassan M;
Lancet; 2014 Feb; 383(9915):436-48. PubMed ID: 24161820
[TBL] [Abstract][Full Text] [Related]
12. Hematopoietic Cell Transplantation for Paroxysmal Nocturnal Hemoglobinuria in the Age of Eculizumab.
Cooper JP; Farah RJ; Stevenson PA; Gooley TA; Storb R; Scott BL
Biol Blood Marrow Transplant; 2019 Jul; 25(7):1331-1339. PubMed ID: 30711779
[TBL] [Abstract][Full Text] [Related]
13. Hematopoietic cell transplantation in chronic granulomatous disease: a study of 712 children and adults.
Chiesa R; Wang J; Blok HJ; Hazelaar S; Neven B; Moshous D; Schulz A; Hoenig M; Hauck F; Al Seraihy A; Gozdzik J; Ljungman P; Lindemans CA; Fernandes JF; Kalwak K; Strahm B; Schanz U; Sedlacek P; Sykora KW; Aksoylar S; Locatelli F; Stepensky P; Wynn R; Lum SH; Zecca M; Porta F; Taskinen M; Gibson B; Matthes S; Karakukcu M; Hauri-Hohl M; Veys P; Gennery AR; Lucchini G; Felber M; Albert MH; Balashov D; Lankester A; Güngör T; Slatter MA
Blood; 2020 Sep; 136(10):1201-1211. PubMed ID: 32614953
[TBL] [Abstract][Full Text] [Related]
14. HLA-mismatched donor and high ferritin level showed poor clinical outcomes after allogeneic hematopoietic cell transplantation in patients with advanced myelofibrosis.
Yoon JH; Min GJ; Park SS; Park S; Lee SE; Cho BS; Kim YJ; Lee S; Kim HJ; Min CK; Cho SG; Lee JW; Eom KS
Ther Adv Hematol; 2020; 11():2040620720936935. PubMed ID: 32994911
[TBL] [Abstract][Full Text] [Related]
15. Hematopoietic stem cell transplantation in children with chronic granulomatous disease: the Spanish experience.
Alonso García L; Bueno Sánchez D; Fernández Navarro JM; Regueiro Garcia A; Blanquer Blanquer M; Benitez Carabante MI; Mozo Del Castillo Y; Fuster Soler JL; Uria Oficialdegui ML; Sisinni L; Perez Martinez A; Diaz de Heredia Rubio C
Front Immunol; 2024; 15():1307932. PubMed ID: 38370416
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic Hematopoietic Cell Transplantation for Chronic Granulomatous Disease: Controversies and State of the Art.
Connelly JA; Marsh R; Parikh S; Talano JA
J Pediatric Infect Dis Soc; 2018 May; 7(suppl_1):S31-S39. PubMed ID: 29746680
[TBL] [Abstract][Full Text] [Related]
17. Allogeneic Hematopoietic Cell Transplantation in Patients with Primary Immunodeficiencies in Korea: Eleven-Year Experience in a Single Center.
Yi ES; Choi YB; Lee NH; Lee JW; Sung KW; Koo HH; Kang ES; Kim YJ; Yoo KH
J Clin Immunol; 2018 Oct; 38(7):757-766. PubMed ID: 30151618
[TBL] [Abstract][Full Text] [Related]
18. Granulocyte Transfusions in Patients with Chronic Granulomatous Disease Undergoing Hematopoietic Cell Transplantation or Gene Therapy.
Arnold DE; Chellapandian D; Parikh S; Mallhi K; Marsh RA; Heimall JR; Grossman D; Chitty-Lopez M; Murguia-Favela L; Gennery AR; Boulad F; Arbuckle E; Cowan MJ; Dvorak CC; Griffith LM; Haddad E; Kohn DB; Notarangelo LD; Pai SY; Puck JM; Pulsipher MA; Torgerson T; Kang EM; Malech HL; Leiding JW
J Clin Immunol; 2022 Jul; 42(5):1026-1035. PubMed ID: 35445907
[TBL] [Abstract][Full Text] [Related]
19. Hematopoietic Cell Transplantation for Congenital Dyserythropoietic Anemia: A Report from the Pediatric Transplant and Cellular Therapy Consortium.
Rangarajan HG; Stanek JR; Abdel-Azim H; Modi A; Haight A; McKinney CM; McKeone DJ; Buchbinder DK; Katsanis E; Abusin GA; Ahmed I; Law J; Silva JG; Mallhi KK; Burroughs LM; Shah N; Shaw PJ; Greiner R; Shenoy S; Pulsipher MA; Abu-Arja R
Transplant Cell Ther; 2022 Jun; 28(6):329.e1-329.e9. PubMed ID: 35288346
[TBL] [Abstract][Full Text] [Related]
20. Reduced-Intensity Conditioning with Busulfan, Fludarabine, and Antithymocyte Globulin for Hematopoietic Cell Transplantation from Unrelated or Haploidentical Family Donors in Patients with Acute Myeloid Leukemia in Remission.
Lee KH; Lee JH; Lee JH; Kim DY; Park HS; Choi EJ; Ko SH; Seol M; Lee YS; Kang YA; Jeon M; Baek S; Kang YL; Kim SH; Yun SC; Kim H; Jo JC; Choi Y; Joo YD; Lim SN
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1555-1566. PubMed ID: 28552421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
